Market Scenario
Endovascular aneurysm repair (EVAR) is a collective term for all treatments that are directed to surgically cure an aortic aneurysm located in the patient’s abdomen. Factors such as reduced recovery times, low-cost hospitalization charges, and technological advancements in repair devices are expected to drive the growth of the market.
The global endovascular aneurysm repair devices market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in April 2018, Vascutek Ltd. and Bolton Medical, subsidiaries of Terumo Corporation, have merged into Terumo Aortic. Combining the aortic companies into a single business, Terumo Corporation aims to grow its presence in the aortic and vascular implants market.
It is estimated that the global endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6485
Regional Market Summary
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The endovascular aneurysm repair devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The Americas is expected to dominate the global endovascular aneurysm repair devices market trends owing to increasing geriatric population, and well-developed healthcare sector. With the increase in the geriatric population, the prevalence of aneurysms is also expected to rise. The Centers for Disease Control and Prevention (CDC) ranks abdominal aortic aneurysm as one of the top 15 causes of mortality in the United States, but only for those between 85 and 89 years. According to the Centers for Disease Control and Prevention, aortic aneurysms were the primary cause of 9,863 deaths in 2014 in the US.
Europe is expected to hold the second largest position in the global endovascular aneurysm repair devices market. The market growth in this region is attributed to the growing prevalence of aneurysms, availability of funds for research, and favorable reimbursement scenario.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.
Asia-Pacific is anticipated show the fastest growing Endovascular Aneurysm Repair Devices Market Share due to the presence of a huge patient population and continuously developing economies.
Key players
- Cardiatis SA,
- Cardinal Health,
- Cook Medical LLC,
- Endologix, INC.,
- Jotec GmbH,
- Medtronic plc,
- Terumo Corporation,
- L. Gore & Associates, Inc.,
- BiFlow Medical Ltd,
- Boston Scientific Corporation,
- Braile Biomédica,
- Endoluminal Sciences Pty Ltd,
- Endospan Ltd.,
- Getinge AB,
- Lemaitre Vascular Inc.
Segmentation
The global endovascular aneurysm repair devices market has been segmented into indication, site, anatomy, and products.
The market, on the basis of indication, has been segmented into the abdominal aortic aneurysm, thoracic aortic aneurysm and others.
The market, based on thoracic aortic aneurysm, has been further segmented into ascending aortic aneurysm, descending aortic aneurysm, thoracoabdominal aortic aneurysm, and thoracic arch aortic aneurysm.
The market, on the basis of the site, has been segmented into infrarenal and pararenal.
The market, based on pararenal site, has been sub-segmented into juxtarenal and suprarenal.
The market, on the basis of anatomy, has been segmented into traditional and complex.
The market, on the basis of products, has been segmented into percutaneous EVAR, fenestrated EVAR, aortic stents and TAA grafts, and others.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/endovascular-aneurysm-repair-devices-market-6485
The global transcatheter pulmonary valve market is expected to reach a value of USD 54.1 million by 2025, according to a new report by Grand View Research, Inc.
The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.In 2015, North America held the majority of market share of nearly 80.6% in the global market.
Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures.
The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region.
The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China.
These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases.
The global Heart Valve Prosthesis Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global Heart Valve Prosthesis market are listed below:Edwards LifesciencesMedtronicAbbottBoston Scientific CorporationLivanovaSymetisJenavalve TechnologyCryolifeTTK Healthcare LimitedColibri Heart ValveLepu Medical TechnologyBraile BiomédicaMicro InterventionalAutotissue Berlin GmbHOthersClick here to get a FREE Sample Copy of the Heart Valve Prosthesis Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-15784The Global Heart Valve Prosthesis Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on Heart Valve Prosthesis MarketThe global pandemic COVID-19 has affected the Heart Valve Prosthesis market directly or indirectly.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
Ask Our Market Expert @ https://www.decisiondatabases.com/contact/ask-questions-15784Why Purchase this Report?A robust research methodology has been followed to collect data for the report.
The global Artificial Tissue Heart Valve Market report offers a comprehensive assessment of the market for the forecast years.
This global industry offers an outlook on the strategic development of the market in terms of revenue profits over the forecast period 2021-2026.The key market players for the global Artificial Tissue Heart Valve market are listed below:Edwards LifesciencesMedtronicAbbottLivanovaBoston ScientificCryolifeSuzhou Jiecheng Medical Technology Co., Ltd.Labcor Laboratórios LtdaBraile BiomédicaMicroPort Scientific CorporationBeijing Balance Medical Technology Co., Ltd.MyvalOthersClick here to get a FREE Sample Copy of the Artificial Tissue Heart Valve Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-16813The Global Artificial Tissue Heart Valve Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
The detailed sales channel is also covered in the study.COVID-19 Impact Analysis on Artificial Tissue Heart Valve MarketThe global pandemic COVID-19 has affected the Artificial Tissue Heart Valve market directly or indirectly.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
Ask Our Market Expert @ https://www.decisiondatabases.com/contact/ask-questions-16813Why Purchase this Report?A robust research methodology has been followed to collect data for the report.
Blood Warmer Devices Market is segmented into three notable segments such as Devices, Patient Type and End User.On the basis of devices, the global blood warmer devices market is segmented into sample warmers, others.
The sample warmers segment is growing at the highest CAGR in the forecast period of 2019 to 2026.In 2018, the Company received CE mark for PrisMax system and its TherMax blood warmer.
The Company intends to launch PrisMax and TherMax in more than 19 countries across Europe with hospitals in France, Denmark, Italy and in Sweden.On the basis of patient type, the market is segmented into pediatric & neonates, adults.
In 2019, pediatric & neonates segment is growing at the highest CAGR in the forecast period of 2019 to 2026.In May 2015, Geratherm Medical AG presented temperature management product at Africa Health 2015.
By this presentation the company enhanced its product portfolio in the South Africa.On the basis of end user, the market is segmented into hospitals, blood banks and transfusion center, home care settings, tissue banks, clinics, others.
In 2019, hospitals segment is growing at the highest CAGR in the forecast period of 2019 to 2026.In June 2018, Belmont Instrument, LLC acquired MTRE Advanced Technologies Ltd. By this acquisition company extended its product portfolio to include non-invasive solution for body temperature management.Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-blood-warmer-devices-sample-warmer-market Scope of the Blood Warmer Devices MarketCurrent and future of Blood Warmer Devices Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersGlobal Blood Warmer Devices Market By Devices (Sample Warmers, Others), Patient Type (Paediatric & Neonates, Adults), End User (Hospitals, Blood Banks and Transfusion Centre, Home Care Settings, Tissue Banks, Clinics, Others), Geography (North America, Asia-Pacific, Europe, Middle East and Africa, South America) Industry Trends and Forecast to 2026 – Industry Trends and Forecast to 2026Blood warmer is a medical device which is used in healthcare facilities for warming fluids and blood products to maintain body temperature to prevent hypothermia in physically traumatized or surgical patients.Browse Related Report Here:Osteoarthritis Therapeutics MarketCardiovascular Disease Drug MarketSome of the leading key players profiled in this study:Some of the major players operating in this market are Smiths Medical Inc., 3M, EMIT CORPORATION, GE Healthcare, Stryker, Barkey GmbH & Co. KG, Geratherm Medical AG, Stihler Electronic GmbH, Belmont Instrument, LLC, Biegler GmbH, Keewell Medical Technology Co. Ltd., Braile Biomédica, ACE MEDICAL, VYAIRE MEDICAL INC, Bıçakcılar, Baxter, Inspiration Healthcare Group plc, SARSTEDT AG & Co. KG, The 37Company, Combat Medical, Ecolab among others.
The global structural heart imaging market size is expected to reach USD 34.1 billion in 2028 at a CAGR of 10.2%, according to a new report by Reports and Data.
Other key factors boosting market growth are technological advancements in structural heart imaging modalities, rapid adoption of advanced imaging techniques, increasing clinical trials of emerging cardiac imaging techniques, and increasing government support for healthcare R activities.
Market players’ increased focus on expanding existing product portfolio and a favorable regulatory scenario for structural heart procedures are expected to stimulate market growth in the near future.Structural Heart Imaging (SHI) is an imaging technique that employs high-resolution cameras for screening of the heart to produce clear images, which aid doctors to accurately diagnose the patient’s cardiac condition.
Rising number of minimally invasive procedures such as Transcatheter Aortic Valve Replacement (TAVR), advances in the techniques, and increasing government support for R activities in the cardiology field create further growth opportunities for players in the global structural heart imaging market over the forecast period.Top Companies Profiled in the Report Include:Koninklijke Philips N.V., Boston Scientific Corporation, CryoLife, Inc., Abbott Laboratories, Siemens Healthineers GmbH, Toshiba Corporation, Medtronic Plc, CardioComm Solutions Inc., Edwards Lifesciences Corporation, Circle Cardiovascular Imaging, Inc., LivaNova PLC, Integer Holdings Corporation, HeartSciences, TomTec Imaging Systems GmbH, Micro Interventional Devices, Inc., Braile Biomédica, Lepu Medical Technology Co., Ltd., Shimadzu Corporation, 3mensio Medical Imaging BV, TTK Healthcare Limited, Pie Medical Imaging B.V., and Aran Biomedical Teoranta.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4100Market Overview:The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4100The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R activities, and government and corporate deals, among others through extensive primary and secondary research.
Blood Warmer Devices/Sample Warmer market is projected to register a healthy CAGR of 8.3% in the forecast period of 2019 to 2026To thrive in this competitive age, business should get knowledgeable about the major accomplishments taking place in the market.
Market research analysis and all the information lends a hand to businesses for the planning of production, product launches, costing, inventory, purchasing and marketing strategies.
To get success in this competitive market place, Blood Warmer Devices/Sample Warmer market research report plays a vital role which provides important and meaningful market insights for any business in the Blood Warmer Devices/Sample Warmer industry.
A team containing domain experts analyses and estimates this market data using well established market statistical and coherent models.
It divides the global market size value & market volume by manufacturers, type, application, and region.
The report puts a light on various inhibitors and motivators in the market for particular product in both quantitative and qualitative manner so that users get precise information.Click Here to Get Latest Sample for Blood Warmer Devices/Sample Warmer Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-blood-warmer-devices-sample-warmer-marketBlood Warmer Devices Market Segmentation:On the basis of devices, the global blood warmer devices market is segmented into sample warmers, others.
